This research is early and doesnt currently change prescribing guidance, but its relevant to both medications equally and worth monitoring as long-term data accumulates
Some patients can stabilize at maintenance doses (e.g., 5 mg or 7.5 mg) for extended periods without losing progress
GHK-Cu dosing protocols for hair growth The most frequently asked question about GHK-Cu for hair comes down to dosing
Binding studies in CHO-K1 cells expressing GLP-1R showed that lixisenatide is a potent and selective GLP-1RA, with a binding affinity to GLP-1R approximately four times greater than that of GLP-1 (88)
Coverage at NY Times, front page today and my input to that piece To view or add a comment, sign in Anyone who had problems with COVID vaccines (who seem like are generally in support of this) have any thoughts
Many on the market use synthetic versions, fillers, harmful preservatives, or low-potency formulas that fail to deliver visible improvements